Should We Expect an Increase in the Number of Cancer Cases in People with Long COVID?

The relationship between viral infections and the risk of developing cancer is well known. Multiple mechanisms participate in and determine this process. The COVID-19 pandemic caused by the SARS-CoV-2 virus has resulted in the deaths of millions of people worldwide. Although the effects of COVID-19 are limited for most people, a large number of people continue to show symptoms for a long period of time (long COVID). Several studies have suggested that cancer could also be a potential long-term complication of the virus; however, the causes of this risk are not yet well understood. In this review, we investigated arguments that could support or reject this possibility.

Elevated levels of serum CDCP1 in individuals recovering from severe COVID-19 disease.

BACKGROUND: COVID-19 survivors report residual lung abnormalities after discharge from the hospital. The aim of this study was to identify biomarkers in serum and induced sputum samples from patients after hospitalization for COVID-19. METHODS: Patients admitted to hospitals in Spain with laboratory-confirmed COVID-19 were recruited for this study. SARS-CoV-2-infected patients were divided into groups with mild/moderate and severe disease according to the severity of their symptoms during hospitalization. Levels of 92 biomarkers were measured in serum and induced sputum samples. RESULTS: A total of 108 patients (46.2% severe cases) were included in this study. The median number of days after the onset of symptoms was 104. A significant difference was observed in diffusing capacity for carbon monoxide (DLCO), an indicator of lung function, whereby DLCO <80% was significantly lower in severe cases (p <0.001). Differences in inflammatory biomarkers were observed between patients with mild/moderate and severe disease. For some biomarkers, correlations in serum and induced sputum levels were detected. Independent predictors of severe disease were DLCO <80% and the serum CDCP1 value. CONCLUSIONS: Higher levels of CDCP1 remain after hospital discharge and are associated with the severity of COVID-19. The possible prognostic implications warrant further investigation.

Maraviroc ameliorates the increased adipose tissue macrophage recruitment induced by a high-fat diet in a mouse model of obesity.

BACKGROUND: Any strategy designed to decrease the macrophage content in adipose tissue (AT) is of great value as a way to decrease inflammation in this fat depot and also as a way to prevent or treat obesity and associated disorders. Maraviroc (MVC), a CCR5 antagonist approved for the treatment of HIV-infected patients, has beneficial effects on metabolism. The objective of this study was to investigate the effects of MVC on AT macrophage recruitment in a mouse model of obesity. The plausible underlying mechanisms of action were also investigated. METHODS: 32 male C57BL/6 mice were randomly assigned to the following groups: control, MVC (300 mg/l MVC in drinking water), high-fat diet (HFD) or HFD+MVC. After 16 weeks of treatment, histopathological and molecular analyses were performed on epididymal fat. RESULTS: Our results demonstrated that MVC reduced the presence of macrophages in epididymal fat despite the ingestion of an HFD. The inhibition of MCP-1 gene expression and JNK signalling pathway along with the upregulation of protective cytokines such as cardiotrophin-1 could contribute to these actions. MVC effects on AT macrophage recruitment were associated with a lower body weight gain and a partial improvement in insulin resistance despite an HFD. CONCLUSIONS: We have demonstrated the ability of MVC to ameliorate the increased AT macrophage recruitment induced by an HFD in a mouse model of obesity. These actions could be of interest when designing antiretroviral treatments in HIV-patients.

Photosynthetic performance and leaf water potential of gulupa (Passiflora edulis Sims, Passifloraceae) in the reproductive phase in three locations in the colombian andes / Desempeño fotosintético y potencial hídrico foliar de gulupa (Passiflora edulis Sims, Passifloraceae) en estado reproductivo en tres localidades de los Andes colombianos

Gulupa, Passiflora edulis Sims (Passifloraceae), is an important fruit due to its organoleptic and nutritional characteristics and its demand in the international market; however, very few studies have been conducted for studying its Ecophysiology. Until now, this crop has spread throughout the country through empirical knowledge without data that indicate the zones that are more suitable for its cultivation. For this reason, gas exchange, chlorophyll fluorescence (photosystem II operating efficiency and maximum quantum efficiency of photosystem II photochemistry) and leaf water potential were measured in three different locations of Cundinamarca department (Chia [2610 m a.s.l., 14 °C], Granada [2230 m a.s.l., 15 °C] and Tena [2090 m a.s.l., 17 °C]), whose climatic conditions were monitored with meteorological stations to evaluate the physiologic performance in each location related to the environmental factors. The results indicate that, even though the photosynthetic capacity was similar and high in Granada and Tena, the water status of the plant, the stomatal control of water loss and recovery of photosystems during the night were more efficient in Granada (p < 0.05). In Tena, the small differences between day and night temperature, humidity, and vapor pressure deficit (VPD) would limited the night water recovery in the plants. Meanwhile, in Chia, the increase of VPD during the day and the low temperatures would decreased the water potential both during the day and during the night, as well as the recovery of photosystem II. Therefore, in conclusion the climatic conditions similar to Granada, which are 18/13 °C day/night, a VPD close to 0.5 KPa, and radiation that did not exceed 1000 μmol photons/m²s favored the good physiological performance of gulupa.

La gulupa, Passiflora edulis Sims (Passifloraceae) es un frutal importante debido a sus características organolépticas, nutricionales y su demanda en el mercado internacional; sin embargo, existen muy pocos estudios relacionados con su ecofisiología. Hasta el momento, el cultivo se ha extendido a través del país por medio de conocimiento empírico sin tener datos que sustenten las zonas más apropiadas para su cultivo. Por esta razón, en el presente estudio se midió el intercambio de gases, la fluorescencia de la clorofila (factor de eficiencia del fotosistema II y eficiencia cuántica fotoquímica máxima del fotosistema II) y el potencial hídrico foliar en tres localidades diferentes del departamento de Cundinamarca (Chía [2610 m s.n.m., 14 °C], Granada [2230 m s.n.m., 15 °C] y Tena [2090 m s.n.m., 17 °C]), cuyas condiciones climáticas fueron monitoreadas con estaciones meteorológicas para evaluar el desempeño fisiológico en cada localidad y relacionarlo con los factores ambientales. Los resultados indican que aunque la capacidad fotosintética fue alta y similar en Granada y Tena, el estado hídrico de la planta, el control estomático de la pérdida de agua y la recuperación de los fotosistemas durante la noche fueron más eficientes en Granada (p < 0,05). En Tena, la estrecha diferencia entre los valores día/noche de temperatura, humedad y déficit de presión de vapor (DPV) limitarían la recuperación hídrica de la planta, mientras que en Chía el aumento de DPV en el día, y las bajas temperaturas disminuirían el potencial hídrico, tanto durante el día como durante la noche, así como la recuperación del fotosistema II. Por tanto, en conclusión, condiciones climáticas cercanas a las de Granada; 18/13 °C día/noche, DPV de 0,5 KPa, y una radiación que no exceda los 1000 μmol fotones/ m²s favorecen el buen desempeño de la planta.

Maraviroc, a CCR5 antagonist, prevents development of hepatocellular carcinoma in a mouse model.

Chronic liver disease may result in a sequential progression through fibrosis, cirrhosis and lead, eventually, to hepatocellular carcinoma (HCC). Hepatic stellate cells (HSC) seem to be responsible for the fibrogenic response through the activation of an autocrine loop involving the chemokine receptor, CCR5. However, the role of CCR5 in HCC remains poorly understood. Since this receptor is also one of the main ports of entry for the human immunodeficiency virus (HIV), several CCR5 inhibitors are being used in the clinic to reduce viral load. We used one of these inhibitors, maraviroc (MVC), in a mouse model of diet-induced HCC to investigate whether this intervention would reduce disease progression. Animals treated with MVC on top of a normal control diet did not present any evidence of toxicity or any morphological change when compared with non-treated mice. Animals treated with MVC presented higher survival, less liver fibrosis, lower levels of liver injury markers and chemokines, less apoptosis, lower proliferation index, and lower tumor burden than their counterparts receiving only the hepatotoxic diet. In addition, MVC inhibits HSC activation markers such as phosphorylation of p38 and ERK, and increases hepatocyte survival. This study suggests that MVC, a well tolerated and clinically characterized drug, may be used as a preventative treatment for HCC. Clinical studies are needed to demonstrate the efficacy of this drug, or other CCR5 inhibitors, in patients with high risk of developing HCC.

Rickettsia parkeri: a Rickettsial pathogen transmitted by ticks in endemic areas for spotted fever rickettsiosis in southern Uruguay / Rickettsia parkeri: patógeno rickettsial transmitido por garrapatas en áreas endémicas de rickettsiosis por fiebre manchada en el sur de Uruguay

At first Rickettsia conorii was implicated as the causative agent of spotted fever in Uruguay diagnosed by serological assays. Later Rickettsia parkeri was detected in human-biting Amblyomma triste ticks using molecular tests. The natural vector of R. conorii, Rhipicephalus sanguineus, has not been studied for the presence of rickettsial organisms in Uruguay. To address this question, 180 R. sanguineus from dogs and 245 A. triste from vegetation (flagging) collected in three endemic localities were screened for spotted fever group (SFG) rickettsiosis in southern Uruguay. Tick extracted DNA pools were subjected to PCR using primers which amplify a fragment of the rickettsial gltA gene. Positive tick DNA pools with these primers were subjected to a second PCR round with primers targeting a fragment of the ompA gene, which is only present in SFG rickettsiae. No rickettsial DNA was detected in R. sanguineus. However, DNA pools of A. triste were found to be positive for a rickettsial organism in two of the three localities, with prevalences of 11.8% to 37.5% positive pools. DNA sequences generated from these PCR-positive ticks corresponded to R. parkeri. These findings, joint with the aggressiveness shown by A. triste towards humans, support previous data on the involvement of A. triste as vector of human infections caused by R. parkeri in Uruguay.

Inicialmente, Rickettsia conorii fue señalada como el agente causal de la fiebre manchada en Uruguay, diagnosticada mediante pruebas serológicas. Posteriormente, Rickettsia parkeri fue detectada mediante técnicas moleculares en garrapatas Amblyomma triste colectadas sobre humanos. El vector natural de R. conorii, Rhipicephalus sanguineus, no ha sido estudiado en cuanto a rickettsias en Uruguay. Para abordar este tema, 180 R. sanguineus fueron colectados sobre perros y 245 A. triste sobre vegetación en tres localidades consideradas endémicas para fiebres manchadas en el sur de Uruguay. El ADN de las garrapatas fue extraído en pools y sometido a una primera PCR utilizando cebadores que amplifican un fragmento del gen gltA, presente en prácticamente todas las especies de Rickettsia. Las muestras positivas fueron sometidas a una segunda PCR con cebadores que amplifican un fragmento del gen ompA, presente sólo en rickettsias del grupo de las fiebres manchadas (GFM). No se detectó ADN rickettsial en R. sanguineus. Sin embargo, muestras de A. triste fueron positivas a rickettsiales en dos de las tres localidades estudiadas, con prevalencias de pools positivos del 11.8 y 37.5% respectivamente. La secuenciación del ADN evidenció la presencia de R. parkeri. Basados en estos resultados junto a los anteriores y la agresividad de A. triste hacia los humanos, se concluye que esta garrapata es vector de rickettsiosis humana por R. parkeri en Uruguay.